How does proficiency testing relate to laboratory improvement? Under the Clinical Laboratories Improvement Act of 1967, the Center for Disease Control (CDC) Licensure and Proficiency Testing Program was given the responsibiity for measuring and improving clinical laboratory performance in the United States. The goal of the Proficiency Testing portion of the program is to improve performance by analyzing test results, detecting deficiencies, evaluating methods, and disseminating reports and other pertinent information to the participants.
Proficiency testing was designed to measure the competence of the analyst at the bench, but it also measures other factors which can influence performance, such as the following: (i) choice of analytical method; (ii) availability of physical or methodological standards; (iii) proficiency of the person who prepared the standards; (iv) reliability of the reagents; (v) instrument design, manufacture, and maintenance; (vi) adequacy of the internal quality control program; (vii) correctness of test interpretation; (viii) accuracy of accessioning samples and recording results; (ix) effectiveness of the proficiency testing process.
Proficiency testing is most valuable as a laboratory improvement tool when the samples are treated as routine patient samples rather than given special treatment. Under these conditions, the test results will reflect the level of performance achieved with patient samples and, consequently, will be of more value to the laboratory.
Proficiency testing can also function as an external quality control program. It is one component of a total quality control system that ensures quality performance in a laboratory; other components are (4) personnel qualification standards, internal quality control programs, preventive maintenance of instruments and equipment, ongoing education and training programs, periodic re-evaluation and updating of procedures, and safety programs.
The Diagnostic Immunology portion of the CDC Proficiency Testing Program functions as follows. Specimens prepared by CDC personnel are distributed to licensed and some nonlicensed (special study and reference laboratories) participants. A Details of specimen preparation and tabulations of results for each survey are included in quarterly summary analyses (10) (11) (12) (13) (18) (19) (20) (21) (22) annual critiques (14, 23, 24) , and professional journal publications (3, 16, 17, (25) (26) (27) . Briefly, specimens were adjusted to the desired reactivity, filtered through sterile membrane filters, and dispensed into suitable vials or tubes. Many of the specimens were lyophilized. The adequacy of samples was confirmed independently by the Diagnostic Immunology Section, by other CDC specialty laboratories, and by reference laboratories. A continuous quality control program ensures that all specimens satisfy preestablished criteria for sterility, antibody titer and stability, and between-vial variability.
Each specimen shipment was packaged and mailed in accordance with postal regulations and included appropriate instructions and report forms. Completed reports were to be postmarked within 2 weeks of the initial shipping date. Responses were compiled and graded, and individual performance rankings were reported to participants within 3 to 4 weeks after responses were received. Acceptable responses were determined from reference laboratory results. Overall response data, which were evaluated and compiled in sUnma8rY analyses or published as separate reports, were later sent to all participants.
Periodically, special surveys were prepared to evaluate analytes being considered for inclusion in the routine proficiency testing program. These surveys were performed by similar methods except that grades were not determined. Table 2 shows the average geometric standard deviations (SG) as a measure of interlaboratory precision achieved by the participants for each analyte by year. The last column is the average for the analyte. For most analytes there has been no significant change with time. For many analytes there are insufficient data to determine whether a change has occurred. The effect of increased precision can be determined from Table 3, which shows the highest and lowest SG for each analyte and the effect the SG has on the 95% limits around a representative value. For a sample with a geometric mean of 1,000 mg of immunoglobulin G per 100 ml, an SG of 1.23 gives a 2-standard deviation range (95% limits) of 661 to 1,513. When the SG is decreased to 1.09, the range becomes 841 to 1,188. This indicates that more results were closer to the geometric mean; that is, the interlaboratory precision was better. The smaller SG values are not always the most recent value, as can be seen from Table 2 .
RESULTS
Interlaboratory comparability of rheumatoid factor results improved with the introduction of a rheumatoid factor reference preparation into the Proficiency Testing Program (3, 17) . Figure  1 shows the results that were achieved in one survey through the use of such a reference preparation. Nonstandardized results had a range of 12 twofold dilutions, but standardized results had a range of 7 twofold dilutions, with 94% of the results within one dilution of the median. Figure 2 shows the improvement in interlaboratory precision over 10 years. Before use of the standard material, the average SG was 2.84; after, it was 2.41. This improvement was also documented by evaluating the percentage of results within one twofold dilution of the median (Fig.  3) . Before introduction of the standard, 74% of the results were in this range; after introduction of the standard, 84% were in this range.
Significant improvement was shown in the performance of the tube test for tularemia (P < 0.01), in which the SG decreased from 2.62 in 1969 to 1.83 in 1979. Performance with the slide test did not noticeably improve, but because of the improvement with the tube tests, overall performance showed some improvement. The overall SG decreased from 2.50 to 2.08 (P < 0.05). The major source of variation in the bacterial agglutination tests is still the antigen, a problem which has been observed since the beginning of the program. The need to develop standard antigens for bacterial agglutination tests and to use Table 4 by decreases in the percentage of results outside the acceptable range. Table 5 shows the percentage of participants using various serum treatments for rubella hemagglutination inhibition testing. The percentage using the nonstandard kaolin serum treatment for hemagglutination inhibition decreased from 65 to 22%. This indicates improvement in performance because the percentage of results outside the acceptable limits for the kaolin procedure has consistently been almost double that for the standard procedures (8, 9) . The reason for some of the fluctuation from year to year is the differences in width of the acceptable ranges (see last column).
The trends in test use for syphilis serology are shown in Table 6 . Although syphilis is not listed in Table 2 , the performance (based on grades) with these tests seems to have been maintained at a high level.
The variation in substrate sensitivity for antinuclear antibody detection is a problem in standardizing this test (1) . The relative sensitivities of substrates used in the indirect immunofluorescence tests for antinuclear antibodies were obtained by ranking the geometric mean titers reported for the 1975 through 1978 surveys. The relative sensitivity of each of the substrates, ranked from highest to lowest, is as follows: rat liver (most sensitive); mouse brain and mouse O°kidney; human cell line and mouse liver; rat kidney, human kidney, and mouse cell line; human leukocytes; and rat brain (least sensitive). Within each group the substrates showed no significant difference in sensitivity. The geometric mean titers reported with the most sensitive substrate are typically two to eight times higher than those reported with the less sensitive substrates. Obviously Table 7 shows the difference in the number and percentage of laboratories correctly detecting HBsAg in proficiency testing samples according to the sensitivity of the test used. Figure 4 and Table 8 show the changes that have occurred in the sensitivities and numbers of tests used by participants to detect HBsAg since the beginning of the CDC Proficiency Testing Program.
In addition, Table 8 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . whether changes had occurred. For most of the analytes, valuable information was derived from the proficiency testing program which permitted improvement in laboratory performance or could permit it in the future. DISCUSSION The syphilis serology evaluation survey which was conducted in 1934 was a predecessor of proficiency testing (29) . The evaluation survey differs from a proficiency test in that the primary purpose of the former is to obtain statistical data concerning the sensitivity, specificity, and reproducibility of the tests, whereas the primary purpose of the latter is to measure the level of proficiency of the laboratories. (29) . In this study, 1,298 sera were collected from individual donors in various disease categories, and each serum was then tested by 38 test procedures in 20 laboratories. The results indicated the sensitivity, specificity, and reproducibility of each test. Because of the logistical problems, cost, and other limitations, it is unlikely that this type of evaluation survey will be conducted in the future, but proficiency testing can provide similar data (15) .
In 1967, the Clinical Laboratories Improvement Act, which required that all laboratories involved in interstate testing be licensed, was passed. One of the licensure requirements is satisfactory performance in a proficiency testing service. To provide this testing, CDC expanded the Laboratory Improvement program, which had previously been assigned to the Bureau of Laboratories.
Since that time, the CDC Proficiency Testing adopting them for use in their laboratories. Use of standards or reference materials is also recommended when they are available. The results from laboratories using standardized methods or reference materials are generally more comparable than results from other laboratories.
It appears from analysis of data in this report that proficiency testing per se did not result in a significant general improvement, but substantial improvement resulted in those areas given special consideration. In many cases the reason for poor performance is beyond the control of the laboratorian and sometimes is even beyond the control of the reagent manufacturers. For example, when there is lack of standardization, laboratorians and manufacturers can do very little to improve interlaboratory comparability. In these areas, professional consensus needs to be obtained on reference methods and materials.
In some areas it appears that even though there was no evidence of improvement, the current performance level may satisfy medical requirements. Since no such limits have been clearly specified, we do not know if these needs have been met. Again, professional consensus needs to be obtained on performance levels required for medical application of the data from immunologic tests.
Laboratories other than those directly involved in the Proficiency Testing Program have also benefited from the program. Some proficiency testing efforts may have resulted in improved laboratory performance that is not detectable by conventional evaluation methods.
For example, a quality control monograph was distributed to try to stimulate the establishment of better quality control procedures in laboratories and thereby eliminate some aberrant re-VOL. 13, 1981 on January 25, 2018 by guest http://jcm.asm.org/ 368 TAYLOR AND FULFORD sults on patient samples (28) . The publication of a comparison between the kinetic and endpoint methods for serum protein quantitation by radial immunodiffusion may have resulted in change to quicker methods (18) . Information about how laboratories are performing with commercial products has been made available to manufacturers, and improvements have been made in some products and package inserts. The total impact of proficiency testing surveys has not yet been measured.
